| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 09/04/2002 | EP0728476B1 Liposome composition |
| 09/04/2002 | EP0702723B1 Biocompatible implant for the expression and secretion in vivo of a therapeutical compound |
| 09/04/2002 | CN1367826A Method for selective electrofusion of at least two fusion partners having cell-like membranes |
| 09/04/2002 | CN1367787A Water soluble SDZ-RAD esters |
| 09/04/2002 | CN1367703A Freeze dried HGF preparations |
| 09/04/2002 | CN1367702A Renal cell carcinoma treatment |
| 09/04/2002 | CN1367692A Nicotine delivery systems |
| 09/04/2002 | CN1367688A Compositions containing immunotoxins and agents that inhibit dendritic cell maturation for inducing immune tolerance to graft |
| 09/04/2002 | CN1367684A Method and composition for treating solid tumors |
| 09/04/2002 | CN1367683A Non-crystalline cefuroxime axetil solid dispersant, process for preparing same and composition for oral administration thereof |
| 09/04/2002 | CN1367682A Drug delivery device, especially for delivery of androgens |
| 09/04/2002 | CN1367680A Pre-formed gel sheet |
| 09/04/2002 | CN1367646A Ectoparasiticidal aqueous suspension formulations of Spinosyn |
| 09/04/2002 | CN1090019C 组合物 The composition |
| 09/04/2002 | CN1090018C Extended release formulation |
| 09/03/2002 | US6444859 Fluoroether compositions and methods for inhibiting their degradation in the presence of a Lewis acid |
| 09/03/2002 | US6444710 Use of certain fatty acid/amino acid soaps to enhance antimicrobial effectiveness of topically administrable pharmaceutical compositions |
| 09/03/2002 | US6444703 4-(4-(4-methylbenzyloxycarbonyl) phanyl)phenyl trans-4-guanidinomethylcyclohexanecarboxylate or acid addition salt thereof and cyclodextrin; use treating ulcers for example |
| 09/03/2002 | US6444689 Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same |
| 09/03/2002 | US6444655 Galactopyranosides and their use |
| 09/03/2002 | US6444646 Use of angiotensin II type 2 receptor agonists in tissue repair |
| 09/03/2002 | US6444447 Polymer grafting by polysaccharide synthases |
| 09/03/2002 | US6444234 Liquid carriers |
| 09/03/2002 | US6444232 Aqueous suspension |
| 09/03/2002 | US6444226 Purification and stabilization of peptide and protein pharmaceutical agents |
| 09/03/2002 | US6444209 Hybrid botulinal neurotoxins |
| 09/03/2002 | US6444200 Interferon and one fatty acid moiety covalently attached to the cytokine that enhances cutaneous delivery; treating infections or enhancing an immune response |
| 09/03/2002 | US6444198 Effervescent laxatives |
| 09/03/2002 | US6444192 Diagnostic imaging of lymph structures |
| 09/03/2002 | US6443898 Therapeutic delivery systems |
| 09/03/2002 | CA2072949C Stick composition with sodium chloride and stearyl alcohol |
| 09/03/2002 | CA2055255C Process for preparing neotrehalose and its uses |
| 09/01/2002 | CA2356201A1 Compounds and compositions for delivering active agents |
| 08/29/2002 | WO2002066512A1 Angiogenesis-inhibitory tripeptides, compositions and their methods of use |
| 08/29/2002 | WO2002066511A2 Long lasting glucagon-like peptide 2 (glp-2) for the treatment of gastrointestinal diseases and disorders |
| 08/29/2002 | WO2002066490A2 Cationic sterol derivatives, ph-sensitive liposomes comprising cationic sterol derivatives and method for loading liposomes with active substances |
| 08/29/2002 | WO2002066489A2 Amphoteric sterols and the use thereof in the production of ph-sensitive liposomes |
| 08/29/2002 | WO2002066469A2 Novel heterocyclic amide derivatives and their use as dopamine d3 receptor ligands |
| 08/29/2002 | WO2002066446A1 Heterocyclic substituted carbonyl derivatives and their use as dopamine d3 receptor ligands |
| 08/29/2002 | WO2002066078A2 Modulated release particles for aerosol delivery |
| 08/29/2002 | WO2002066077A2 Modulated release particles for aerosol delivery |
| 08/29/2002 | WO2002066070A1 Pharmaceutical compositions containing decoy and method of using the same |
| 08/29/2002 | WO2002066067A2 Albumin-based drug delivery system and antimicrobial peptides |
| 08/29/2002 | WO2002066066A1 Terminally-branched polymeric linkers and polymeric conjugates containing the same |
| 08/29/2002 | WO2002066061A1 Active oxygen generator containing photosensitizer for ultrasonic therapy |
| 08/29/2002 | WO2002066058A1 Modified anti-egfr antibodies with reduced immunogenicity |
| 08/29/2002 | WO2002066056A2 Synthetic vaccines comprising polyhydroxypolymer carriers |
| 08/29/2002 | WO2002066052A1 Use of a conjugate of il-6 and an il-6 receptor in tumor therapy |
| 08/29/2002 | WO2002066018A2 Transdermal therapeutic system containing testosterone and method for the production thereof |
| 08/29/2002 | WO2002066016A2 Mucoadhesive dispersible pharmaceutical preparation for active-agent dosing in veterinary and human medicine |
| 08/29/2002 | WO2002066014A2 Cubic liquid crystalline compositions and methods for their preparation |
| 08/29/2002 | WO2002066012A2 Amphoteric liposomes and the use thereof |
| 08/29/2002 | WO2002066011A1 Modulated release particles for aerosol delivery |
| 08/29/2002 | WO2002066010A1 Modulated release particles for aerosol delivery |
| 08/29/2002 | WO2002066009A1 Modulated release particles for aerosol delivery |
| 08/29/2002 | WO2002066008A1 Modulated release particles for aerosol delivery |
| 08/29/2002 | WO2002066007A1 Gel emulsions in the form of o/w emulsions having a hydrocolloid content |
| 08/29/2002 | WO2002066006A1 Sustained-release suspension of ceftiofur hydrochloride |
| 08/29/2002 | WO2002066005A1 Composition and method for controlled release injections |
| 08/29/2002 | WO2002066003A1 Composition for use in electroporation |
| 08/29/2002 | WO2002066002A2 Pharmaceutical formulation |
| 08/29/2002 | WO2002065994A1 Cosmetics and process for producing cosmetics |
| 08/29/2002 | WO2002065988A2 Terminally-branched polymeric linkers and polymeric conjugates containing the same |
| 08/29/2002 | WO2002065986A2 Transporters comprising spaced arginine moieties |
| 08/29/2002 | WO2002065985A2 Methods of treating diabetes mellitus |
| 08/29/2002 | WO2002065981A2 Chemotherapeutic composition using calcium phosphate paste |
| 08/29/2002 | WO2002065959A1 Urine incontinence device and corresponding method |
| 08/29/2002 | WO2002065943A2 Ocular tear growth factor-like protein |
| 08/29/2002 | WO2002065859A1 Emulsions and aqueous dispersions of phytosterols |
| 08/29/2002 | WO2002065834A2 Novel formulations of carvedilol |
| 08/29/2002 | WO2002047668A3 Novel medicament compositions based on anticholinesterase drugs and on ciclesonides |
| 08/29/2002 | WO2002045753A3 Oral extended release formulation of gepirone |
| 08/29/2002 | WO2002034286B1 Methods for treating endocrine disorders |
| 08/29/2002 | WO2002020723A3 Compositions and methods for targeting peptides in humans in vivo |
| 08/29/2002 | WO2002002506A3 Compounds to treat alzheimer's disease |
| 08/29/2002 | WO2001095943A3 Prodrug compounds with an oligopeptide having an isoleucine residue |
| 08/29/2002 | WO2001091808A3 Bioconjugates of nanoparticles as radiopharmaceuticals |
| 08/29/2002 | WO2001089579A3 Composition for delivery of compounds to cells |
| 08/29/2002 | WO2001085093A3 Compounds and methods for modulating cerebral amyloid angiopathy |
| 08/29/2002 | WO2001082975A3 Membrane-permeant peptide complexes for medical imaging |
| 08/29/2002 | WO2001041758A8 Valnemulin formulation |
| 08/29/2002 | WO2001035941A8 Novel composition based on a thiazolidinedione and metformin and use |
| 08/29/2002 | WO2001005427A9 Psca: prostate stem cell antigen and uses thereof |
| 08/29/2002 | WO2001005373A9 Methods and apparatus for preparation of lipid vesicles |
| 08/29/2002 | WO2001000247A9 Peptide-lipid conjugates, liposomes and liposomal drug delivery |
| 08/29/2002 | WO2000066709A9 Zymogen activation system |
| 08/29/2002 | WO2000061788A3 Poly(dipeptide) as a drug carrier |
| 08/29/2002 | WO2000056866A9 Akt-3 nucleic acids, polypeptides, and uses thereof |
| 08/29/2002 | WO1999064055A9 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht4 receptors |
| 08/29/2002 | US20020120141 Dye labeled imidazoquinoline compounds |
| 08/29/2002 | US20020120109 Biologically active proteins |
| 08/29/2002 | US20020120100 Peptide transporters that specifically target certain cell types for the delivery of drugs and therapeutic agents |
| 08/29/2002 | US20020120015 Emulsification with a long chain polymer surfactant and a short chain fatty acid surfactant; thermodynamic stability |
| 08/29/2002 | US20020120009 Compounds and compositions for delivering active agents |
| 08/29/2002 | US20020120002 2-tri-halo-1-methyl-N-acetyl-5-methoxytryptamine and a carrier |
| 08/29/2002 | US20020119997 Aqueous solution; topical applying |
| 08/29/2002 | US20020119990 Liposomal camptothecins and uses thereof |
| 08/29/2002 | US20020119987 Analgesics, anesthetic; side effect reduction |
| 08/29/2002 | US20020119955 Modified prodrug forms of AP/AMP |
| 08/29/2002 | US20020119954 Mixture with polysiloxane |